Article

Comprehensive Druggable Genome-Wide Mendelian Randomization Reveals Therapeutic Targets for Kidney Diseases

2024-06-05

Abstract excerpt

<h4>Background</h4> Kidney diseases, including membranous nephropathy (MN), IgA nephropathy (IgAN), and chronic kidney disease (CKD), pose significant global health challenges due to their high prevalence and severe outcomes. There is still an urgent need to discover new targets for treating kidney diseases. Mendelian randomization (MR) has been widely used to repurpose licensed drugs and discover novel therapeuti...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 3707a485-8b29-5ac9-ba03-685925533c70
DOI: 10.1101/2024.06.01.24308209

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Comprehensive Druggable Genome-Wide Mendelian Randomization Reveals Therapeutic Targets for Kidney DiseasesDOI 10.1101/2024.06.01.24308209Read

Identification of druggable targets in acute kidney injury by proteome- and transcriptome-wide Mendelian randomization and bioinformatics analysisSemantic proximity Read

Identification of therapeutic targets for chronic kidney disease through Mendelian randomization analysis of druggable genesSemantic proximity Read

Membranous Nephropathy: Muti-omics Mendelian randomization and colocalization analysisSemantic proximity Read

Systematic prioritization of potential therapeutic targets for glomerulonephritis using multi-omics Mendelian randomization.Semantic proximity Read

Identification of Therapeutic Targets for Hyperuricemia: Systematic Genome-Wide Mendelian Randomization and Colocalization AnalysisSemantic proximity Read

Proteome-wide mendelian randomization identifies novel therapeutic targets for chronic kidney disease.Semantic proximity Read

Identification of diagnostic biomarkers for diabetes nephropathy by multi-chip integrated bioinformatics combining machine-learning strategies and mendelian randomizationSemantic proximity Read

Therapeutic Targets for Diabetic Kidney Disease: Proteome-Wide Mendelian Randomization and Colocalization Analyses.Semantic proximity Read

Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney.Semantic proximity Read

Integrated multiple-microarray analysis and mendelian randomization to identify novel targets involved in diabetic nephropathySemantic proximity Read

Based on systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for diabetes.Semantic proximity Read

Genetically proxied therapeutic inhibition of kidney function drug targets and type 2 diabetes in Africans: A Mendelian randomization studySemantic proximity Read